ADAPTIVE BIOTECHNOLOGIES CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 759.72 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-26
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 759.72K shares, a 24.66% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 759.72K shares, a 24.66% decline from fiscal 2024.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 1.01M shares, a 37.45% decline from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.61M shares, a 63.57% decline from fiscal 2022.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 4.43M shares, a 45.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-26 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-26 | 759.72K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-05 | 759.72K shares 10-Q · filed 2025-11-05 | 759.72K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 759.72K shares 10-Q · filed 2025-08-05 | 759.72K shares derived: sum of 3 quarters · filed 2025-08-05 | 759.72K shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 759.72K shares 10-Q · filed 2025-05-01 | 759.72K shares derived: sum of 2 quarters · filed 2025-05-01 | 759.72K shares derived: sum of 3 quarters · filed 2025-05-01 | 759.72K shares derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-03 | 0.00 shares derived: sum of 3 quarters · filed 2025-03-03 | 1.01M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-07 | 1.01M shares 10-Q · filed 2024-11-07 | 1.01M shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 1.01M shares 10-Q · filed 2024-08-01 | 1.01M shares derived: sum of 3 quarters · filed 2024-08-01 | 1.01M shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 1.01M shares 10-Q · filed 2024-05-07 | 1.01M shares derived: sum of 2 quarters · filed 2024-05-07 | 1.01M shares derived: sum of 3 quarters · filed 2024-05-07 | 1.01M shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 0.00 shares derived: sum of 2 quarters · filed 2024-02-29 | 0.00 shares derived: sum of 3 quarters · filed 2024-02-29 | 1.61M shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-09 | 1.61M shares 10-Q · filed 2023-11-09 | 1.61M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | 1.61M shares 10-Q · filed 2023-08-02 | 1.61M shares derived: sum of 3 quarters · filed 2023-08-02 | 1.64M shares derived: sum of 4 quarters · filed 2023-08-02 |
| 2023-03-31 | 1.61M shares 10-Q · filed 2023-05-03 | 1.61M shares derived: sum of 2 quarters · filed 2023-05-03 | 1.64M shares derived: sum of 3 quarters · filed 2023-05-03 | 2.31M shares derived: sum of 4 quarters · filed 2023-05-03 |
| 2022-12-31 | 1.69K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | 27.80K shares derived: sum of 2 quarters · filed 2023-02-14 | 694.49K shares derived: sum of 3 quarters · filed 2023-02-14 | 4.43M shares 10-K · filed 2023-02-14 |
| 2022-09-30 | 26.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 692.79K shares derived: sum of 2 quarters · filed 2022-11-03 | 4.42M shares 10-Q · filed 2022-11-03 | 5.07M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 666.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 4.40M shares 10-Q · filed 2022-08-03 | 5.04M shares derived: sum of 3 quarters · filed 2022-08-03 | 5.46M shares derived: sum of 4 quarters · filed 2022-08-03 |
| 2022-03-31 | 3.73M shares 10-Q · filed 2022-05-04 | 4.38M shares derived: sum of 2 quarters · filed 2022-05-04 | 4.79M shares derived: sum of 3 quarters · filed 2022-05-04 | 5.15M shares derived: sum of 4 quarters · filed 2022-05-04 |
| 2021-12-31 | 644.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 1.06M shares derived: sum of 2 quarters · filed 2022-02-15 | 1.42M shares derived: sum of 3 quarters · filed 2022-02-15 | 3.05M shares 10-K · filed 2022-02-15 |
| 2021-09-30 | 415.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 772.02K shares derived: sum of 2 quarters · filed 2021-11-03 | 2.41M shares 10-Q · filed 2021-11-03 | 2.63M shares derived: sum of 4 quarters · filed 2021-11-03 |
| 2021-06-30 | 356.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | 1.99M shares 10-Q · filed 2021-08-04 | 2.21M shares derived: sum of 3 quarters · filed 2021-08-04 | 2.64M shares derived: sum of 4 quarters · filed 2021-08-04 |
| 2021-03-31 | 1.64M shares 10-Q · filed 2021-05-05 | 1.86M shares derived: sum of 2 quarters · filed 2021-05-05 | 2.28M shares derived: sum of 3 quarters · filed 2021-05-05 | 2.58M shares derived: sum of 4 quarters · filed 2021-05-05 |
| 2020-12-31 | 221.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 647.25K shares derived: sum of 2 quarters · filed 2021-02-24 | 948.85K shares derived: sum of 3 quarters · filed 2021-02-24 | 3.24M shares 10-K · filed 2021-02-24 |
| 2020-09-30 | 425.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 727.48K shares derived: sum of 2 quarters · filed 2020-11-10 | 3.02M shares 10-Q · filed 2020-11-10 | 3.14M shares derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | 301.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 2.59M shares 10-Q · filed 2020-08-10 | 2.72M shares derived: sum of 3 quarters · filed 2020-08-10 | |
| 2020-03-31 | 2.29M shares 10-Q · filed 2020-05-12 | 2.42M shares derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2019-12-31 | 122.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | 4.19M shares 10-K · filed 2020-02-26 | ||
| 2019-09-30 | 4.07M shares 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | 4.76M shares 10-K · filed 2020-02-26 | |||
| 2017-12-31 | 1.60M shares 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |